Marco Ratta, Donia Skanji, Zhaoyang Teng, Gaëlle Saint‐Hilary, Mauro Gasparini, Pavel Mozgunov. Including Quantitative Benefit‐Risk Assessment in Seamless Phase 2/3 Designs With Dose Selection. // Statistics in Medicine. – 2026. – DOI: 10.1002/sim.70790. – URL: https://onlinelibrary.wiley.com/doi/10.1002/sim.70790?af=R
Marco Ratta, Donia Skanji, Zhaoyang Teng, Gaëlle Saint‐Hilary, Mauro Gasparini, & Pavel Mozgunov (2026). Including Quantitative Benefit‐Risk Assessment in Seamless Phase 2/3 Designs With Dose Selection. Statistics in Medicine. https://doi.org/10.1002/sim.70790
Marco Ratta, et al. “Including Quantitative Benefit‐Risk Assessment in Seamless Phase 2/3 Designs With Dose Selection.” Statistics in Medicine, 2026. doi:10.1002/sim.70790.
@article{Ratta2026,
title = {Including Quantitative Benefit‐Risk Assessment in Seamless Phase 2/3 Designs With Dose Selection},
author = {Ratta, Marco and Skanji, Donia and Teng, Zhaoyang and Saint‐Hilary, Gaëlle and Gasparini, Mauro and Mozgunov, Pavel},
journal = {Statistics in Medicine},
year = {2026},
doi = {10.1002/sim.70790},
url = {https://onlinelibrary.wiley.com/doi/10.1002/sim.70790?af=R}
}